Engineered protein has potential for new anti- inflammatory treatment
March 11th, 2011 - 4:57 pm ICT by ANIWashington, March 11 (ANI): Scientists at NYU Langone Medical Center have created a new protein molecule derived from the growth factor progranulin, which may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis.
“The development of this protein extends our understanding of the molecular mechanisms that drive the growth factors and cytokines control of cartilage development and arthritis,” said Chuan-ju Liu, the lead researcher.
“Whether the protein accounts for all of the anti-inflammatory effects we observed in the study needs to replicated, but we are very encouraged by these initial results,” he said.
The molecule created and used in this study, called ATSTTRIN (antagonist of TNF/TNFR signaling via targeting to TNF receptors), is a peptide constructed from segments of proteins that originate within a cell, which has a high affinity and specificity for binding to tumor necrosis factor receptors (TNFR).
The researchers suggest that this progranulin-derived protein could result in alternative treatments to those suffering from chronic autoimmune diseases such as rheumatoid arthritis, Crohn’s diseases, ulcerative colitis, ankylosing spondylitis, plaque psoriasis and psoriatic arthritis.
The study is published in the March 10, 2011 issue of Science. (ANI)
- Genes causing arthritis isolated - Jul 12, 2011
- Re-engineered toxins can treat asthma, arthritis - Jan 02, 2012
- Four new psoriasis 'hotspots' identified - Oct 19, 2010
- Largest single collection of psoriasis DNA samples offers hope to sufferers - Sep 02, 2010
- 'Master switch' for key immune cells in inflammatory diseases found - Jan 17, 2011
- New drug restores responsiveness to morphine - Jan 31, 2011
- Arthritis wonder drugs may hold key for many more diseases - Jul 18, 2008
- Obese teens 'at increased risk of psoriatic arthritis' - Jul 20, 2010
- First-ever international guidelines for psoriatic arthritis treatment published - Oct 27, 2008
- New signaling pathway linked to inflammatory disease discovered - Dec 15, 2010
- Study examines aspirin's ability to protect against colorectal cancer - Mar 10, 2011
- 'Bouncer' protein halts rheumatoid arthritis - Sep 22, 2011
- Two-sided immune cell could be harnessed to shrink tumours: Study - Oct 29, 2010
- Regular statin use 'cuts rheumatoid arthritis risk' - Sep 08, 2010
- New therapeutic target for asthma, other lung disorders identified - Apr 18, 2011
Tags: alternative treatments, antagonist, autoimmune diseases, cartilage development, growth factors, inflammatory diseases, initial results, march 11, molecular mechanisms, nyu langone, peptide, plaque psoriasis, progranulin, protein molecule, psoriasis, receptors, rheumatoid arthritis, specificity, tumor necrosis factor, ulcerative colitis